Willis NJ, Mahy W, Sipthorp J, Zhao Y, Woodward HL, Atkinson BN, Bayle ED, Svensson F, Frew S, Jeganathan F, Monaghan A, Benvegnu S, Jolly S, Vecchia L, Ruza RR, Kjaer S, Howell SA, Snidjers AP, Bictash M, Salinas PC, Vincent JP, Jones EY, Whiting P, Fish PV (2022) <br />Design of a potent, selective and brain penetrant inhibitor of Wnt-deactivating enzyme Notum by optimization of a crystallographic fragment hit<br /><i>Journal of Medicinal Chemistry</i> <b>65</b>: 7212<br /><br />Zhao Y, Mahy W, Willis NJ, Woodward HL, Steadman D, Bayle ED, Atkinson BN, Sipthorp J, Vecchia L, Ruza RR, Harlos K, Jeganathan F, Constantinou S, Costa A, Kjaer S, Bictash M, Salinas PC, Whiting P, Vincent JP, Fish PV, Jones EY (2022) <br />Structural Analysis and Development of Notum Fragment Screening Hits<br /><i>ACS Chem Neurosci</i> <b>13</b>: 2060<br /><br />Bayle ED, Svensson F, Atkinson BN, Steadman D, Willis NJ, Woodward HL, Whiting P, Vincent JP, Fish PV (2021) <br />Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling<br /><i>Journal of Medicinal Chemistry</i> <br /><br />Flanagan DJ, Pentinmikko N, Luopajarvi K, Willis NJ, Gilroy K, Raven AP, McGarry L, Englund JI, Webb AT, Scharaw S, Nasreddin N, Hodder MC, Ridgway RA, Minnee E, Sphyris N, Gilchrist E, Najumudeen AK, Romagnolo B, Perret C, Williams AC, Clevers H, Nummela P, Lahde M, Alitalo K, Hietakangas V, Hedley A, Clark W, Nixon C, Kirschner K, Jones EY, Ristimaki A, Leedham SJ, Fish PV, Vincent JP, Katajisto P, Sansom OJ (2021) <br />NOTUM from Apc-mutant cells biases clonal competition to initiate cancer<br /><i>Nature</i> <br /><br />Zhao Y, Schuhmacher LN, Roberts M, Kakugawa S, Bineva-Todd G, Howell S, O'Reilly N, Perret C, Snijders AP, Vincent JP, Jones EY (2021) <br />Notum Deacylates Octanoylated Ghrelin<br /><i>Mol Metab</i> <br /><br />Mahy W, Willis NJ, Zhao Y, Woodward HL, Svensson F, Sipthorp J, Vecchia L, Ruza RR, Hillier J, Kjr S, Frew S, Monaghan A, Bictash M, Salinas PC, Whiting P, Vincent JP, Jones EY, Fish PV (2020) <br />5-Phenyl-1,3,4-oxadiazol-2(3H)-ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit<br /><i>Journal of Medicinal Chemistry</i> <b>63</b>: 12942<br /><br />Kakugawa S, Langton PF, Zebisch M, Howell SA, Chang TH, Liu Y, Feizi T, Bineva G, O'Reilly N, Snijders AP, Jones EY, Vincent JP (2015) <br />Notum deacylates Wnt proteins to suppress signalling activity<br /><i>Nature</i> <b>519</b>: 187<br /><br />Checler F, Grassi J, Vincent JP (1994) <br />Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities<br /><i>Journal of Neurochemistry</i> <b>62</b>: 756<br /><br />Checler F, Grassi J, Masson P, Vincent JP (1990) <br />Monoclonal antibodies allow precipitation of esterasic but not peptidasic activities associated with butyrylcholinesterase<br /><i>Journal of Neurochemistry</i> <b>55</b>: 750<br /><br />